IL1B and COVID-19: Several studies have suggested the role of IL-6 in the pathogenetic mechanisms of COVID-19 [30–35]: when SARS-CoV-2 infects the respiratory tract, it induces a release of pro-inflammatory cytokines, including interleukin (IL)-1beta and IL-6 [31].